论文部分内容阅读
目的评价可手术切除的原发性肝癌(primaryhepatocellulareareinoma,PHC)合并门静脉癌栓(portalveintumorthrombus,PV.IT)患者仅行肝动脉化疗栓塞(transeatheterarterialchemo—emboliza—tion,TACE)和经皮肝穿刺门静脉化疗(pereutaneoustranshepaticportalveinchemotherapy,PVC)联合TACE的治疗效果。方法选择可手术切除的PHC合并PVlTr患者36例,随机分成A、B